Mark L. Pacala - 12 Nov 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Mark L. Pacala
Issuer symbol
TOI
Transactions as of
12 Nov 2024
Net transactions value
$0
Form type
4
Filing time
18 Nov 2024, 18:52:13 UTC
Previous filing
28 Dec 2023
Next filing
25 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Other $0 -20,248 -15% $0.000000 114,781 12 Nov 2024 Direct F1
transaction TOI Common stock Other $0 -30,372 -26% $0.000000 84,409 12 Nov 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.
F2 Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.